Evaluation of Protein Channel-Attenuated Salmonella Vaccines
Description: PROJECT NARRATIVE The proposed project entitled, "Evaluation of Protein Channel-Attenuated Salmonella Vaccines" will construct a live vaccine that aims at preventing human salmonellosis. Salmonella enterica is a disease that causes a variety of food and water-borne illnesses, such as gastroenteritis and typhoid fever. It can infect a wide range of animal hosts and also humans. Of the three common Typhoid fever disease, S. Typhi alone is estimated to cause approximately 16 million cases, with 600,000 deaths annually worldwide and 600 fatalities recently occurring each year in the United States. To make the situation even worse, this disease has acquired resistance to the antibiotics previously used to treat it. Recently, our laboratory invented a new strategy for inactivating the Salmonella. This new strategy is totally different from the conventionally used virulence gene inactivation method. If demonstrated effective in Salmonella, this strategy will be also applicable to other enterobacteria, as well. Therefore, this project will benefit not only the USA but also other countries epidemic with salmonellosis.
Funding type: research
Funder scheme: R21
Start date: 2009-06-01
End date: 2011-05-31
Investigator: XINGHONG YANG
Institution: MONTANA STATE UNIVERSITY - BOZEMAN
Subfield: Food Science
Domain: Life Sciences
Funded outputs count: 11
Funder award ID: R21AI080960
OpenAlex ID: G674594388